BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8093571)

  • 1. Dopamine-acetylcholine-glutamate interactions in the striatum. A working hypothesis.
    Di Chiara G; Morelli M
    Adv Neurol; 1993; 60():102-6. PubMed ID: 8093571
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 3. Glutamate and Parkinson's disease.
    Greenberg DA
    Ann Neurol; 1994 Jun; 35(6):639. PubMed ID: 7911652
    [No Abstract]   [Full Text] [Related]  

  • 4. Striatal molecular mechanisms and motor dysfunction in Parkinson's disease.
    Chase TN; Konitsiotis S; Oh JD
    Adv Neurol; 2001; 86():355-60. PubMed ID: 11553996
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where do you think you are going? The NMDA-D1 receptor trap.
    Cepeda C; Levine MS
    Sci STKE; 2006 May; 2006(333):pe20. PubMed ID: 16670371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
    Schotanus SM; Chergui K
    J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic and dopaminergic modulation of potassium conductances in neostriatal neurons.
    Kitai ST; Surmeier DJ
    Adv Neurol; 1993; 60():40-52. PubMed ID: 8380527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomeric assembly of dopamine D1 and glutamate NMDA receptors: molecular mechanisms and functional implications.
    Fiorentini C; Missale C
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1025-8. PubMed ID: 15506954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of dopamine and met-enkephalin on the background and evoked spike activity of rat neostriatal neurons].
    Godukhin OV
    Fiziol Zh SSSR Im I M Sechenova; 1984 Nov; 70(11):1551-8. PubMed ID: 6151523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic activation of Fos and the rat model of Parkinson's disease.
    Cole DG
    Adv Neurol; 1993; 60():334-7. PubMed ID: 8380526
    [No Abstract]   [Full Text] [Related]  

  • 13. Thirty years of dopamine research.
    Carlsson A
    Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH; Kupsch A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
    Pickel VM; Colago EE; Mania I; Molosh AI; Rainnie DG
    Neuroscience; 2006 Oct; 142(3):671-90. PubMed ID: 16905271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.
    Nomoto M; Fukuda T
    Adv Neurol; 1993; 60():119-22. PubMed ID: 8093574
    [No Abstract]   [Full Text] [Related]  

  • 17. GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease.
    Zhang X; Feng ZJ; Chergui K
    J Neurochem; 2014 May; 129(4):581-90. PubMed ID: 24475872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated cocaine administration increases N-methyl-d-aspartate NR1 subunit, extracellular signal-regulated kinase and cyclic AMP response element-binding protein phosphorylation and glutamate release in the rat dorsal striatum.
    Lee DK; Bian S; Rahman MA; Shim YB; Shim I; Choe ES
    Eur J Pharmacol; 2008 Aug; 590(1-3):157-62. PubMed ID: 18598691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
    Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
    J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.
    Fiorentini C; Rizzetti MC; Busi C; Bontempi S; Collo G; Spano P; Missale C
    Mol Pharmacol; 2006 Mar; 69(3):805-12. PubMed ID: 16365282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.